Velan Capital Investment Management LP
Q2 2026 13F filing
Updated 27 days ago53 disclosed positions worth $164.2M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PRAX PRAXIS PRECISION MEDICINES I | $29.7M | 88.8K | 18.10% | — |
| 2 | M MPLT MAPLIGHT THERAPEUTICS INC | $17.7M | 492.9K | 10.76% | — |
| 3 | ? N/A SUTRO BIOPHARMA INC | $17M | 512.2K | 10.36% | — |
| 4 | ? N/A IMMIX BIOPHARMA INC | $11.2M | 1.08M | 6.81% | — |
| 5 | T TARA PROTARA THERAPEUTICS INC | $10.9M | 2.84M | 6.62% | — |
| 6 | A AAVXF ABIVAX SA | $8.7M | 65.6K | 5.33% | — |
| 7 | ? N/A TENAX THERAPEUTICS INC | $8M | 550.0K | 4.87% | — |
| 8 | A AVR ANTERIS TECHNOLOGIES GLOBAL | $6.9M | 700.0K | 4.20% | — |
| 9 | ? N/A EDESA BIOTECH INC | $6.7M | 827.5K | 4.10% | — |
| 10 | A AVTX AVALO THERAPEUTICS INC | $6M | 324.5K | 3.65% | — |
| 11 | E EVMN EVOMMUNE INC | $5.9M | 446.3K | 3.61% | — |
| 12 | X XNCR XENCOR INC | $4.1M | 255.0K | 2.50% | — |
| 13 | R RZLT REZOLUTE INC | $3.9M | 750.0K | 2.38% | — |
| 14 | H HRTX HERON THERAPEUTICS INC | $3.7M | 8.75M | 2.28% | — |
| 15 | V VRCA VERRICA PHARMACEUTICALS INC | $2.9M | 471.6K | 1.76% | — |
| 16 | B BEPC C4 THERAPEUTICS INC | $2.7M | 570.0K | 1.62% | — |
| 17 | E EPRX EUPRAXIA PHARMACEUTICALS INC | $2.3M | 352.0K | 1.42% | — |
| 18 | A ADMA ADMA BIOLOGICS INC | $2.1M | 250.0K | 1.27% | — |
| 19 | ? N/A REIN THERAPEUTICS INC | $1.8M | 1.70M | 1.08% | — |
| 20 | L LYEL LYELL IMMUNOPHARMA INC | $1.5M | 105.0K | 0.90% | — |
| 21 | N NSRX NASUS PHARMA LTD | $1.3M | 359.4K | 0.77% | — |
| 22 | P PROF PROFOUND MED CORP | $1.1M | 170.3K | 0.69% | — |
| 23 | J JSPRW JASPER THERAPEUTICS INC | $1M | 2.42M | 0.62% | — |
| 24 | ? N/A TENAX THERAPEUTICS INC | $1000K | 68.7K | 0.61% | — |
| 25 | P PB PROTAGONIST THERAPEUTICS INC | $454K | 3.7K | 0.28% | — |
| 26 | C CTMX CYTOMX THERAPEUTICS INC. | $450K | 120.0K | 0.27% | — |
| 27 | N NMRA NEUMORA THERAPEUTICS INC. | $391K | 230.0K | 0.24% | — |
| 28 | N NRIX NURIX THERAPEUTICS INC | $388K | 16.0K | 0.24% | — |
| 29 | O OVID OVID THERAPEUTICS INC | $350K | 130.0K | 0.21% | — |
| 30 | D DTIL PRECISION BIOSCIENCES INC | $314K | 40.0K | 0.19% | — |
| 31 | M MLYS MINERALYS THERAPEUTICS INC | $297K | 11.0K | 0.18% | — |
| 32 | M MGNX MACROGENICS INC | $277K | 60.0K | 0.17% | — |
| 33 | C CRBP CORBUS PHARMACEUTICALS HLDGS | $244K | 26.0K | 0.15% | — |
| 34 | ? N/A ARTIVA BIOTHERAPEUTICS INC | $243K | 25.0K | 0.15% | — |
| 35 | Q QCOM REPLIMUNE GROUP INC | $221K | 20.0K | 0.13% | — |
| 36 | S SNDX SYNDAX PHARMACEUTICALS INC | $219K | 10.0K | 0.13% | — |
| 37 | I IMNM IMMUNOME INC | $212K | 10.0K | 0.13% | — |
| 38 | T TECX TECTONIC THERAPEUTIC INC | $206K | 6.0K | 0.13% | — |
| 39 | R RCL ROCKET PHARMACEUTICALS INC | $205K | 60.0K | 0.13% | — |
| 40 | K KPTI KARYOPHARM THERAPEUTICS INC | $195K | 20.0K | 0.12% | — |
| 41 | ? N/A AN2 THERAPEUTICS INC | $194K | 40.0K | 0.12% | — |
| 42 | V VRDN VIRIDIAN THERAPEUTICS INC | $184K | 10.0K | 0.11% | — |
| 43 | S SCYX SCYNEXIS INC | $163K | 40.0K | 0.10% | — |
| 44 | ? N/A QUOIN PHARMACEUTICALS LTD | $157K | 32.4K | 0.10% | — |
| 45 | ? N/A XILIO THERAPEUTICS INC | $137K | 14.3K | 0.08% | — |
| 46 | ? N/A INSPIREMD INC | $104K | 148.1K | 0.06% | — |
| 47 | J JSPRW JASPER THERAPEUTICS INC | $103K | 245.3K | 0.06% | — |
| 48 | ? N/A KALARIS THERAPEUTICS INC | $102K | 25.0K | 0.06% | — |
| 49 | L LRMR LARIMAR THERAPEUTICS INC | $101K | 33.0K | 0.06% | — |
| 50 | P PRQR PROQR THRAPEUTICS N V | $84K | 45.0K | 0.05% | — |